Code: MTA8611 | Publication Date: Sep 2025 |
Several growth factors impacting the Real World Evidence Solutions Market include increasing demand for data-based decision-making across the healthcare system, increasing use of electronic health records, and increasing dependence on real-world data in clinical trials. Further, regulatory support and improvements in analytics are stimulating market growth.
The Real World Evidence Solutions Marketplace is on a definite path of growth that is transforming healthcare analytics. The trend of using real-world evidence (RWE) is ramping up in drug development pipelines, providing pharmaceutical companies with the tools they need to develop more efficient trials and objectively monitor post-market safety. Another trend involves a variety of data, allowing for the centralization of data made up of different data sources, such as wearables, claims data, and others. Both the Real World Evidence Solutions Marketplace and vendors of the RWE solutions are witnessing a shift towards more tools offered as cloud-based platforms, ensuring steps in their solutions that provide scale, safety, and access to healthcare data.
The Real World Evidence Solutions Marketplace is also undergoing a number of emerging developments as organizations move toward an advanced analytics platform of their own. Companies, now more than ever, are advancing with disease information modelling. Another emerging trend in the Real World Evidence Solutions Marketplace is the potential for decentralized trial design to utilize real-world evidence that creates new opportunities for patients to participate more easily. Moreover, there is consideration of AI-enabled platforms that have potential for integrating unstructured datasets, which can present more advanced predictive modelling and decision making across healthcare purposes and therapeutic areas.
Some of the leading companies include: